NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · MID CAP
OrthoPediatrics Corp. KIDS
11 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$236.3M
▲ 15.4% vs FY2024
EPS · FY25
$-1.69
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-11.3%
Net margin · FY25
-16.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 236.3M
Revenue, FY2025 · full 11-year series below
Revenue
Net income
The company lost 17 cents on every revenue dollar this year.
Per share
USD -1.69
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-11.3%
Return on equity, FY2025
ROE
Operating margin-16.6%
Net margin-16.8%
Return on assets-8.1%
Each USD of equity lost 11 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+27.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+24.6%
+27.2%
+22.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.03B
Shares outstanding, FY2025
Change, 5 years+28.3%
Change, 10 years—
The share count grew 28% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 508.6M
total assets, end of FY2025
Total assetsUSD 508.6M
EquityUSD 346.6M
CashUSD 19.6M
Gross debtUSD 101.7M
Net debtUSD 82.1M
Current ratio5.55×
Net debt stands at 24% of equity.
History
11 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue $B
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−1.69
−1.64
−0.92
0.06
−0.84
−1.82
−0.94
−0.96
−5.86
−7.14
−7.27
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
−0
−0
−67
−0
−0
ROE %
−11.3
−10.3
−5.6
0.4
−7.1
−17.5
−12.3
−18.6
·
·
·
Shares out B
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
42 of 42
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed